Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Pax protein inhibitors that suppress target gene expression and cancer cell proliferation. | Cell Chem Biol | 2022 | 34822752 | PubTator, text mining | PubMed |
| Importance of Early Genetic Sequencing in Neonates Admitted to NICU with Recurrent Hypernatremia: Results of a Prospective Cohort Study. | Neonatology | 2022 | 34802008 | PubTator, text mining | PubMed |
| Does a third intermediate model for the vomeronasal processing of information exist? Insights from the macropodid neuroanatomy. | Brain Struct Funct | 2022 | 34800143 | PubTator, text mining | PubMed |
| Innate Bacteriostatic Mechanisms Defend the Urinary Tract. | Annu Rev Physiol | 2022 | 34780258 | PubTator, text mining | PubMed |
| MAGED2 controls vasopressin-induced aquaporin-2 expression in collecting duct cells. | J Proteomics | 2022 | 34775100 | PubTator, text mining | PubMed |
| "ADPKD-omics": determinants of cyclic AMP levels in renal epithelial cells. | Kidney Int | 2022 | 34757121 | PubTator, text mining | PubMed |
| Systems Biology of the Vasopressin V2 Receptor: New Tools for Discovery of Molecular Actions of a GPCR. | Annu Rev Pharmacol Toxicol | 2022 | 34579536 | PubTator, text mining | PubMed |
| Advances in Hydrogen/Deuterium Exchange Mass Spectrometry and the Pursuit of Challenging Biological Systems. | Chem Rev | 2022 | 34493042 | PubTator, text mining | PubMed |
| Effect of oral tolvaptan for 1 year in patients with functional mitral regurgitation. | Heart Vessels | 2022 | 34476570 | PubTator, text mining | PubMed |
| Differential diagnosis between syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome in children over 1 year: proposal for a simple algorithm. | Pediatr Nephrol | 2022 | 34468821 | PubTator, text mining | PubMed |
| Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects. | Br J Pharmacol | 2022 | 33817785 | PubTator, text mining | PubMed |
| Urinary exosome proteomic profiling defines stage-specific rapid progression of autosomal dominant polycystic kidney disease and tolvaptan efficacy. | BBA Adv | 2021 | 37082007 | PubTator, text mining | PubMed |
| Genetic Architecture of Childhood Kidney and Urological Diseases in China. | Phenomics | 2021 | 36939782 | PubTator, text mining | PubMed |
| Fetomaternal Acid-Base Balance and Electrolytes during Pregnancy. | Indian J Crit Care Med | 2021 | 35615608 | PubTator, text mining | PubMed |
| Exploring the therapeutic mechanisms of Cassia glauca in diabetes mellitus through network pharmacology, molecular docking and molecular dynamics. | RSC Adv | 2021 | 35492478 | PubTator, text mining | PubMed |
| Potential therapeutic targets and molecular details of anthocyan-treated inflammatory bowel disease: a systematic bioinformatics analysis of network pharmacology. | RSC Adv | 2021 | 35423341 | PubTator, text mining | PubMed |
| [Physiological role of the apelin receptor: implication in body fluid homeostasis and hyponatremia]. | Biol Aujourdhui | 2021 | 35275056 | PubTator, text mining | PubMed |
| The Evolution of Oxytocin and Vasotocin Receptor Genes in Jawed Vertebrates: A Clear Case for Gene Duplications Through Ancestral Whole-Genome Duplications. | Front Endocrinol (Lausanne) | 2021 | 35185783 | PubTator, text mining | PubMed |
| Tolvaptan Add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction (DR-AHF): Design and Rationale. | Front Cardiovasc Med | 2021 | 35155599 | PubTator, text mining | PubMed |
| Inhibitory Effect and Potential Mechanism of Lactobacillus plantarum YE4 against Dipeptidyl Peptidase-4. | Foods | 2021 | 35010205 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=33